Keck Hospital of USC receives 10th “A” Leapfrog safety grade

The hospital is once again nationally recognized for its commitment to patient safety

2025-05-01

(Press-News.org) LOS ANGELES — Keck Hospital of USC earned an “A” Hospital Safety Grade from The Leapfrog Group, an independent national nonprofit watchdog focused on patient safety.   

This is the 10th “A” grade the hospital has received since 2019.

“The Leapfrog Group is one of the most trusted names in health care, and it is a tremendous achievement to once again receive the highest safety grade possible,” said Marty Sargeant, MBA, CEO of Keck Medical Center of USC, which includes Keck Hospital.

Leapfrog assigns a letter grade to general hospitals across the country based on over 30 performance measures reflecting the systems hospitals have in place to prevent errors, accidents, injuries and infections.

“The safety of our patients is the hospital’s top priority,” said Stephanie Hall, MD, MHA, chief medical officer of Keck Medical Center. “This grade reflects our staff’s continual efforts to provide high-quality care patients can trust.”

The Leapfrog hospital grading system is peer-reviewed, fully transparent and free to the public. Grades are updated twice annually, in the fall and spring.

To see Keck Hospital’s full grade details and access hospital safety tips for patients, please visit HospitalSafetyGrade.org.

In November 2024, Keck Hospital earned an “A” in The Leapfrog Group’s fall Hospital Safety Grade and in September 2024, Vizient, Inc. named the hospital a top performer along with a five-star rating, the highest possible. 

###

Keck Hospital of USC is part of Keck Medicine of USC. For more information about Keck Medicine of USC, please visit news.KeckMedicine.org.

END

ELSE PRESS RELEASES FROM THIS DATE:

Gabapentinoids unlikely to be directly linked to self-harm risk

2025-04-30

Treatment with gabapentinoids - drugs such as gabapentin and pregabalin - is not directly associated with an increased risk of self-harm, finds a UK study published by The BMJ today. However, rates of self-harm were higher before and shortly after treatment, highlighting the need for close monitoring of patients throughout their treatment journey, say the researchers. Gabapentinoids are prescribed for conditions such as epilepsy, nerve pain, and anxiety disorders. Previous studies have raised concerns about ...

No-touch vein harvesting has meaningful benefits for heart bypass patients

2025-04-30

‘No-touch’ vein harvesting significantly reduces the risk of graft failure up to three years after coronary artery bypass surgery compared with conventionally harvested vein grafts, finds a study from China published by The BMJ today. The no-touch technique also translates into meaningful clinical benefits for patients, such as lower rates of heart attacks and need for repeat revascularisation (a procedure to restore blood flow to blocked veins), say the researchers. A coronary artery bypass graft (CABG) is a surgical procedure used to improve blood flow and oxygen supply to the heart in patients with coronary heart disease. It involves grafting a healthy ...

Single DNA mutation disrupts key tumour-suppressing pathways, elevating blood cancer risk

2025-04-30

GLOBAL: Australian researchers have discovered that a single mutation in the DNA sequence for a methylation enzyme dysregulates key tumour-suppressing pathways, opening up new avenues for blood cancer treatment. The findings of this research confirm mutant DNA methyltransferase 3A (DNMT3A) as a potential target for effective blood cancer treatment. One of the most common DNA mutations found in blood cancers is in the sequence encoding DNMT3A. Between 20 and 25% of adults with acute myeloid leukaemia (AML) have mutant DNMT3A.1 This ...

ChatGPT vs students

2025-04-30

ChatGPT vs students: study reveals who writes better (and it’s not the AI) AI generated essays don’t yet live up to the efforts of real students - according to new research from the University of East Anglia (UK). A new study published today compared the work of 145 real students with essays generated by ChatGPT. While the AI essays were found to be impressively coherent and grammatically sound, they fell short in one crucial area – they lacked a personal touch. As the line between human and machine writing ...

Semaglutide treats liver disease in two thirds of patients

2025-04-30

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE phase 3 clinical trial published today in the New England Journal of Medicine shows treating patients with the substance can halt and even reverse the disease. The placebo-controlled outcome trial of participants with a life-threatening form of liver disease known as Metabolic dysfunction associated steatohepatitis (MASH) was conducted at 253 clinical sites across 37 countries around the world. This is the first regulatory-level trial showing the benefit ...

Gene therapy restores immune function and extends lives of children with rare immune disorder

2025-04-30

An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life-threatening immune disorder called severe leukocyte adhesion deficiency-I, or LAD-I, in an international clinical trial co-led by UCLA. LAD-I is a genetic condition that affects approximately one in a million people in the world. It is caused by mutations in the gene that produces CD18, a protein that enables white blood cells to travel from the bloodstream to infection sites. In the absence of this critical protein, individuals with severe LAD-I — most of whom are diagnosed within ...

VCU-led research highlights semaglutide’s potential for treating fatty liver disease

2025-04-30

EMBARGOED FOR RELEASE 5 PM EDT, APRIL 30 CONTACT: A.J. Hostetler VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health Phone: 804-543-8656 (cell) Email: AJ.Hostetler@vcuhealth.org VCU-led research highlights semaglutide’s potential for treating fatty liver disease International study shows drug reverses liver damage in patients. RICHMOND, Va. (April 30, 2025) – An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance in Ozempic and Wegovy can halt and even reverse a common liver disease that affects millions worldwide. Led by Arun Sanyal, M.D., of the Stravitz-Sanyal Institute ...

Does your biological age affect your risk of dementia?

2025-04-30

MINNEAPOLIS — People whose biological age is higher than their chronological age may be more likely to develop dementia than people whose biological age matches or is lower than their chronological age, according to a study published on April 30, 2025, online in Neurology®, the medical journal of the American Academy of Neurology. Biological age is based on biomarkers of aging such as lung function, blood pressure and cholesterol. The study does not prove that advanced biological age causes dementia; it only shows an association. “With the rising impact of dementia around the world, identifying risk factors and implementing preventive ...

Research collaboration charts global four-stage evolution of inflammatory bowel disease

2025-04-30

Researchers with the University of Calgary and the Chinese University of Hong Kong (CUHK) led an international collaboration that found inflammatory bowel disease (IBD) progresses through four predictable epidemiological stages as it spreads globally. Published in Nature, the study forecasts a major rise in IBD prevalence in Canada by 2045. Researchers say pinpointing where each region sits on the trajectory gives health-care systems a clear roadmap for anticipating and managing IBD today and in the decades to follow. “Our analysis draws on a century worth of historical epidemiologic data. The findings enable health authorities ...

Ecological Society of America announces 2025 Fellows

2025-04-30

The Ecological Society of America is pleased to announce its 2025 Fellows. The Society’s fellowship program recognizes the many ways in which its members contribute to ecological research, communication, education, management and policy. This year, the ESA Governing Board has confirmed eight new Fellows and ten new Early Career Fellows. Fellows are members who have made outstanding contributions to a wide range of fields served by ESA, including, but not restricted to, those that advance or apply ecological knowledge in academics, ...

World's first practical surface-emitting laser for optical fiber communications developed: advancing miniaturization, energy efficiency, and cost reduction of light sources

Keck Hospital of USC receives 10th “A” Leapfrog safety grade

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: